Oligonucleotides Market in France - Manufacturing and Consumption, Outlook and Forecast 2020-2026
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
This report contains market size and forecasts of Oligonucleotides in France, including the following market information:
France Oligonucleotides Market Revenue, 2015-2020, 2021-2026, ($ millions)
France Oligonucleotides Market Consumption, 2015-2020, 2021-2026, (Million MT)
France Oligonucleotides Production Capacity, 2015-2020, 2021-2026, (Million MT)
Top Five Competitors in France Oligonucleotides Market 2019 (%)
The global Oligonucleotides market was valued at 1165.5 million in 2019 and is projected to reach US$ 1685.8 million by 2026, at a CAGR of 9.7% during the forecast period. While the Oligonucleotides market size in France was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oligonucleotides manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Oligonucleotides production and consumption in France
Total Market by Segment:
France Oligonucleotides Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Million MT)
France Oligonucleotides Market Segment Percentages, By Type, 2019 (%)
France Oligonucleotides Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Oligonucleotides Market Competitors Revenues in France, by Players 2015-2020 (Estimated), ($ millions)
Total Oligonucleotides Market Competitors Revenues Share in France, by Players 2019 (%)
Total France Oligonucleotides Market Competitors Sales, by Players 2015-2020 (Estimated), (Million MT)
Total France Oligonucleotides Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
This report contains market size and forecasts of Oligonucleotides in France, including the following market information:
France Oligonucleotides Market Revenue, 2015-2020, 2021-2026, ($ millions)
France Oligonucleotides Market Consumption, 2015-2020, 2021-2026, (Million MT)
France Oligonucleotides Production Capacity, 2015-2020, 2021-2026, (Million MT)
Top Five Competitors in France Oligonucleotides Market 2019 (%)
The global Oligonucleotides market was valued at 1165.5 million in 2019 and is projected to reach US$ 1685.8 million by 2026, at a CAGR of 9.7% during the forecast period. While the Oligonucleotides market size in France was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oligonucleotides manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Oligonucleotides production and consumption in France
Total Market by Segment:
France Oligonucleotides Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Million MT)
France Oligonucleotides Market Segment Percentages, By Type, 2019 (%)
- DNA Oligos
- RNA Oligos
France Oligonucleotides Market Segment Percentages, By Application, 2019 (%)
- Pharmaceutical
- Research
- Diagnostic
The report also provides analysis of leading market participants including:
Total Oligonucleotides Market Competitors Revenues in France, by Players 2015-2020 (Estimated), ($ millions)
Total Oligonucleotides Market Competitors Revenues Share in France, by Players 2019 (%)
Total France Oligonucleotides Market Competitors Sales, by Players 2015-2020 (Estimated), (Million MT)
Total France Oligonucleotides Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- Integrated DNA Technologies
- Agilent
- Sigma-aldrich
- Eurofins Genomics
- L.G.C Biosearch Technologies
- Eurogentec S.A
- Nitto Denko Avecia Inc
- GenScript
- BBI Life Sciences
- GeneDesign
- TriLink BioTechnologies
- SGS DNA
- LC Sciences
- Twist Bioscience
- Creative Biogene
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Oligonucleotides Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 France Oligonucleotides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: FRANCE OLIGONUCLEOTIDES OVERALL MARKET SIZE
2.1 France Oligonucleotides Market Size: 2020 VS 2026
2.2 France Oligonucleotides Revenue, Prospects & Forecasts: 2015-2026
2.3 France Oligonucleotides Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Oligonucleotides Players in France (including Foreign and Local Companies)
3.2 Top France Oligonucleotides Companies Ranked by Revenue
3.3 France Oligonucleotides Revenue by Companies (including Foreign and Local Companies)
3.4 France Oligonucleotides Sales by Companies (including Foreign and Local Companies)
3.5 France Oligonucleotides Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Oligonucleotides Companies in France, by Revenue in 2019
3.7 France Manufacturers Oligonucleotides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oligonucleotides Players in France
3.8.1 List of France Tier 1 Oligonucleotides Companies
3.8.2 List of France Tier 2 and Tier 3 Oligonucleotides Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - France Oligonucleotides Market Size Markets, 2020 & 2026
4.1.2 DNA Oligos
4.1.3 RNA Oligos
4.2 By Type - France Oligonucleotides Revenue & Forecasts
4.2.1 By Type - France Oligonucleotides Revenue, 2015-2020
4.2.2 By Type - France Oligonucleotides Revenue, 2021-2026
4.2.3 By Type - France Oligonucleotides Revenue Market Share, 2015-2026
4.3 By Type - France Oligonucleotides Sales & Forecasts
4.3.1 By Type - France Oligonucleotides Sales, 2015-2020
4.3.2 By Type - France Oligonucleotides Sales, 2021-2026
4.3.3 By Type - France Oligonucleotides Sales Market Share, 2015-2026
4.4 By Type - France Oligonucleotides Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - France Oligonucleotides Market Size, 2020 & 2026
5.1.2 Pharmaceutical
5.1.3 Research
5.1.4 Diagnostic
5.2 By Application - France Oligonucleotides Revenue & Forecasts
5.2.1 By Application - France Oligonucleotides Revenue, 2015-2020
5.2.2 By Application - France Oligonucleotides Revenue, 2021-2026
5.2.3 By Application - France Oligonucleotides Revenue Market Share, 2015-2026
5.3 By Application - France Oligonucleotides Sales & Forecasts
5.3.1 By Application - France Oligonucleotides Sales, 2015-2020
5.3.2 By Application - France Oligonucleotides Sales, 2021-2026
5.3.3 By Application - France Oligonucleotides Sales Market Share, 2015-2026
5.4 By Application - France Oligonucleotides Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Integrated DNA Technologies
6.1.1 Integrated DNA Technologies Corporate Summary
6.1.2 Integrated DNA Technologies Business Overview
6.1.3 Integrated DNA Technologies Oligonucleotides Major Product Offerings
6.1.4 Integrated DNA Technologies Sales and Revenue in France (2015-2020)
6.1.5 Integrated DNA Technologies Key News
6.2 Agilent
6.2.1 Agilent Corporate Summary
6.2.2 Agilent Business Overview
6.2.3 Agilent Oligonucleotides Major Product Offerings
6.2.4 Agilent Sales and Revenue in France (2015-2020)
6.2.5 Agilent Key News
6.3 Sigma-aldrich
6.3.1 Sigma-aldrich Corporate Summary
6.3.2 Sigma-aldrich Business Overview
6.3.3 Sigma-aldrich Oligonucleotides Major Product Offerings
6.3.4 Sigma-aldrich Sales and Revenue in France (2015-2020)
6.3.5 Sigma-aldrich Key News
6.4 Eurofins Genomics
6.4.1 Eurofins Genomics Corporate Summary
6.4.2 Eurofins Genomics Business Overview
6.4.3 Eurofins Genomics Oligonucleotides Major Product Offerings
6.4.4 Eurofins Genomics Sales and Revenue in France (2015-2020)
6.4.5 Eurofins Genomics Key News
6.5 L.G.C Biosearch Technologies
6.5.1 L.G.C Biosearch Technologies Corporate Summary
6.5.2 L.G.C Biosearch Technologies Business Overview
6.5.3 L.G.C Biosearch Technologies Oligonucleotides Major Product Offerings
6.5.4 L.G.C Biosearch Technologies Sales and Revenue in France (2015-2020)
6.5.5 L.G.C Biosearch Technologies Key News
6.6 Eurogentec S.A
6.6.1 Eurogentec S.A Corporate Summary
6.6.2 Eurogentec S.A Business Overview
6.6.3 Eurogentec S.A Oligonucleotides Major Product Offerings
6.6.4 Eurogentec S.A Sales and Revenue in France (2015-2020)
6.6.5 Eurogentec S.A Key News
6.7 Nitto Denko Avecia Inc
6.6.1 Nitto Denko Avecia Inc Corporate Summary
6.6.2 Nitto Denko Avecia Inc Business Overview
6.6.3 Nitto Denko Avecia Inc Oligonucleotides Major Product Offerings
6.4.4 Nitto Denko Avecia Inc Sales and Revenue in France (2015-2020)
6.7.5 Nitto Denko Avecia Inc Key News
6.8 GenScript
6.8.1 GenScript Corporate Summary
6.8.2 GenScript Business Overview
6.8.3 GenScript Oligonucleotides Major Product Offerings
6.8.4 GenScript Sales and Revenue in France (2015-2020)
6.8.5 GenScript Key News
6.9 BBI Life Sciences
6.9.1 BBI Life Sciences Corporate Summary
6.9.2 BBI Life Sciences Business Overview
6.9.3 BBI Life Sciences Oligonucleotides Major Product Offerings
6.9.4 BBI Life Sciences Sales and Revenue in France (2015-2020)
6.9.5 BBI Life Sciences Key News
6.10 GeneDesign
6.10.1 GeneDesign Corporate Summary
6.10.2 GeneDesign Business Overview
6.10.3 GeneDesign Oligonucleotides Major Product Offerings
6.10.4 GeneDesign Sales and Revenue in France (2015-2020)
6.10.5 GeneDesign Key News
6.11 TriLink BioTechnologies
6.11.1 TriLink BioTechnologies Corporate Summary
6.11.2 TriLink BioTechnologies Oligonucleotides Business Overview
6.11.3 TriLink BioTechnologies Oligonucleotides Major Product Offerings
6.11.4 TriLink BioTechnologies Sales and Revenue in France (2015-2020)
6.11.5 TriLink BioTechnologies Key News
6.12 SGS DNA
6.12.1 SGS DNA Corporate Summary
6.12.2 SGS DNA Oligonucleotides Business Overview
6.12.3 SGS DNA Oligonucleotides Major Product Offerings
6.12.4 SGS DNA Sales and Revenue in France (2015-2020)
6.12.5 SGS DNA Key News
6.13 LC Sciences
6.13.1 LC Sciences Corporate Summary
6.13.2 LC Sciences Oligonucleotides Business Overview
6.13.3 LC Sciences Oligonucleotides Major Product Offerings
6.13.4 LC Sciences Sales and Revenue in France (2015-2020)
6.13.5 LC Sciences Key News
6.14 Twist Bioscience
6.14.1 Twist Bioscience Corporate Summary
6.14.2 Twist Bioscience Oligonucleotides Business Overview
6.14.3 Twist Bioscience Oligonucleotides Major Product Offerings
6.14.4 Twist Bioscience Sales and Revenue in France (2015-2020)
6.14.5 Twist Bioscience Key News
6.15 Creative Biogene
6.15.1 Creative Biogene Corporate Summary
6.15.2 Creative Biogene Oligonucleotides Business Overview
6.15.3 Creative Biogene Oligonucleotides Major Product Offerings
6.15.4 Creative Biogene Sales and Revenue in France (2015-2020)
6.15.5 Creative Biogene Key News
6.16 General Biosystems
6.16.1 General Biosystems Corporate Summary
6.16.2 General Biosystems Oligonucleotides Business Overview
6.16.3 General Biosystems Oligonucleotides Major Product Offerings
6.16.4 General Biosystems Sales and Revenue in France (2015-2020)
6.16.5 General Biosystems Key News
7 OLIGONUCLEOTIDES PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Oligonucleotides Production Capacity and Value in France, Situation Analysis and Prediction, 2015-2026
7.1.1 France Oligonucleotides Production Capacity, 2015-2026
7.1.2 France Oligonucleotides Production 2015-2026
7.1.3 France Oligonucleotides Production Value 2015-2026
7.2 Key Local Oligonucleotides Manufacturers in France
7.2.1 France Key Local Oligonucleotides Manufacturers Production Capacity
7.2.2 France Key Local Oligonucleotides Manufacturers Production
7.2.3 France Key Local Oligonucleotides Manufacturers Production Value
7.2.4 The Proportion of Oligonucleotides Production Sold in France and Sold Other Than France by Manufacturers
7.3 Oligonucleotides Export and Import in France
7.3.1 France Oligonucleotides Export Market
7.3.2 France Oligonucleotides Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for France Oligonucleotides Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON OLIGONUCLEOTIDES SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Oligonucleotides Distributors and Sales Agents in France
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
1.1 Oligonucleotides Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 France Oligonucleotides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: FRANCE OLIGONUCLEOTIDES OVERALL MARKET SIZE
2.1 France Oligonucleotides Market Size: 2020 VS 2026
2.2 France Oligonucleotides Revenue, Prospects & Forecasts: 2015-2026
2.3 France Oligonucleotides Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Oligonucleotides Players in France (including Foreign and Local Companies)
3.2 Top France Oligonucleotides Companies Ranked by Revenue
3.3 France Oligonucleotides Revenue by Companies (including Foreign and Local Companies)
3.4 France Oligonucleotides Sales by Companies (including Foreign and Local Companies)
3.5 France Oligonucleotides Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Oligonucleotides Companies in France, by Revenue in 2019
3.7 France Manufacturers Oligonucleotides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oligonucleotides Players in France
3.8.1 List of France Tier 1 Oligonucleotides Companies
3.8.2 List of France Tier 2 and Tier 3 Oligonucleotides Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - France Oligonucleotides Market Size Markets, 2020 & 2026
4.1.2 DNA Oligos
4.1.3 RNA Oligos
4.2 By Type - France Oligonucleotides Revenue & Forecasts
4.2.1 By Type - France Oligonucleotides Revenue, 2015-2020
4.2.2 By Type - France Oligonucleotides Revenue, 2021-2026
4.2.3 By Type - France Oligonucleotides Revenue Market Share, 2015-2026
4.3 By Type - France Oligonucleotides Sales & Forecasts
4.3.1 By Type - France Oligonucleotides Sales, 2015-2020
4.3.2 By Type - France Oligonucleotides Sales, 2021-2026
4.3.3 By Type - France Oligonucleotides Sales Market Share, 2015-2026
4.4 By Type - France Oligonucleotides Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - France Oligonucleotides Market Size, 2020 & 2026
5.1.2 Pharmaceutical
5.1.3 Research
5.1.4 Diagnostic
5.2 By Application - France Oligonucleotides Revenue & Forecasts
5.2.1 By Application - France Oligonucleotides Revenue, 2015-2020
5.2.2 By Application - France Oligonucleotides Revenue, 2021-2026
5.2.3 By Application - France Oligonucleotides Revenue Market Share, 2015-2026
5.3 By Application - France Oligonucleotides Sales & Forecasts
5.3.1 By Application - France Oligonucleotides Sales, 2015-2020
5.3.2 By Application - France Oligonucleotides Sales, 2021-2026
5.3.3 By Application - France Oligonucleotides Sales Market Share, 2015-2026
5.4 By Application - France Oligonucleotides Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Integrated DNA Technologies
6.1.1 Integrated DNA Technologies Corporate Summary
6.1.2 Integrated DNA Technologies Business Overview
6.1.3 Integrated DNA Technologies Oligonucleotides Major Product Offerings
6.1.4 Integrated DNA Technologies Sales and Revenue in France (2015-2020)
6.1.5 Integrated DNA Technologies Key News
6.2 Agilent
6.2.1 Agilent Corporate Summary
6.2.2 Agilent Business Overview
6.2.3 Agilent Oligonucleotides Major Product Offerings
6.2.4 Agilent Sales and Revenue in France (2015-2020)
6.2.5 Agilent Key News
6.3 Sigma-aldrich
6.3.1 Sigma-aldrich Corporate Summary
6.3.2 Sigma-aldrich Business Overview
6.3.3 Sigma-aldrich Oligonucleotides Major Product Offerings
6.3.4 Sigma-aldrich Sales and Revenue in France (2015-2020)
6.3.5 Sigma-aldrich Key News
6.4 Eurofins Genomics
6.4.1 Eurofins Genomics Corporate Summary
6.4.2 Eurofins Genomics Business Overview
6.4.3 Eurofins Genomics Oligonucleotides Major Product Offerings
6.4.4 Eurofins Genomics Sales and Revenue in France (2015-2020)
6.4.5 Eurofins Genomics Key News
6.5 L.G.C Biosearch Technologies
6.5.1 L.G.C Biosearch Technologies Corporate Summary
6.5.2 L.G.C Biosearch Technologies Business Overview
6.5.3 L.G.C Biosearch Technologies Oligonucleotides Major Product Offerings
6.5.4 L.G.C Biosearch Technologies Sales and Revenue in France (2015-2020)
6.5.5 L.G.C Biosearch Technologies Key News
6.6 Eurogentec S.A
6.6.1 Eurogentec S.A Corporate Summary
6.6.2 Eurogentec S.A Business Overview
6.6.3 Eurogentec S.A Oligonucleotides Major Product Offerings
6.6.4 Eurogentec S.A Sales and Revenue in France (2015-2020)
6.6.5 Eurogentec S.A Key News
6.7 Nitto Denko Avecia Inc
6.6.1 Nitto Denko Avecia Inc Corporate Summary
6.6.2 Nitto Denko Avecia Inc Business Overview
6.6.3 Nitto Denko Avecia Inc Oligonucleotides Major Product Offerings
6.4.4 Nitto Denko Avecia Inc Sales and Revenue in France (2015-2020)
6.7.5 Nitto Denko Avecia Inc Key News
6.8 GenScript
6.8.1 GenScript Corporate Summary
6.8.2 GenScript Business Overview
6.8.3 GenScript Oligonucleotides Major Product Offerings
6.8.4 GenScript Sales and Revenue in France (2015-2020)
6.8.5 GenScript Key News
6.9 BBI Life Sciences
6.9.1 BBI Life Sciences Corporate Summary
6.9.2 BBI Life Sciences Business Overview
6.9.3 BBI Life Sciences Oligonucleotides Major Product Offerings
6.9.4 BBI Life Sciences Sales and Revenue in France (2015-2020)
6.9.5 BBI Life Sciences Key News
6.10 GeneDesign
6.10.1 GeneDesign Corporate Summary
6.10.2 GeneDesign Business Overview
6.10.3 GeneDesign Oligonucleotides Major Product Offerings
6.10.4 GeneDesign Sales and Revenue in France (2015-2020)
6.10.5 GeneDesign Key News
6.11 TriLink BioTechnologies
6.11.1 TriLink BioTechnologies Corporate Summary
6.11.2 TriLink BioTechnologies Oligonucleotides Business Overview
6.11.3 TriLink BioTechnologies Oligonucleotides Major Product Offerings
6.11.4 TriLink BioTechnologies Sales and Revenue in France (2015-2020)
6.11.5 TriLink BioTechnologies Key News
6.12 SGS DNA
6.12.1 SGS DNA Corporate Summary
6.12.2 SGS DNA Oligonucleotides Business Overview
6.12.3 SGS DNA Oligonucleotides Major Product Offerings
6.12.4 SGS DNA Sales and Revenue in France (2015-2020)
6.12.5 SGS DNA Key News
6.13 LC Sciences
6.13.1 LC Sciences Corporate Summary
6.13.2 LC Sciences Oligonucleotides Business Overview
6.13.3 LC Sciences Oligonucleotides Major Product Offerings
6.13.4 LC Sciences Sales and Revenue in France (2015-2020)
6.13.5 LC Sciences Key News
6.14 Twist Bioscience
6.14.1 Twist Bioscience Corporate Summary
6.14.2 Twist Bioscience Oligonucleotides Business Overview
6.14.3 Twist Bioscience Oligonucleotides Major Product Offerings
6.14.4 Twist Bioscience Sales and Revenue in France (2015-2020)
6.14.5 Twist Bioscience Key News
6.15 Creative Biogene
6.15.1 Creative Biogene Corporate Summary
6.15.2 Creative Biogene Oligonucleotides Business Overview
6.15.3 Creative Biogene Oligonucleotides Major Product Offerings
6.15.4 Creative Biogene Sales and Revenue in France (2015-2020)
6.15.5 Creative Biogene Key News
6.16 General Biosystems
6.16.1 General Biosystems Corporate Summary
6.16.2 General Biosystems Oligonucleotides Business Overview
6.16.3 General Biosystems Oligonucleotides Major Product Offerings
6.16.4 General Biosystems Sales and Revenue in France (2015-2020)
6.16.5 General Biosystems Key News
7 OLIGONUCLEOTIDES PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Oligonucleotides Production Capacity and Value in France, Situation Analysis and Prediction, 2015-2026
7.1.1 France Oligonucleotides Production Capacity, 2015-2026
7.1.2 France Oligonucleotides Production 2015-2026
7.1.3 France Oligonucleotides Production Value 2015-2026
7.2 Key Local Oligonucleotides Manufacturers in France
7.2.1 France Key Local Oligonucleotides Manufacturers Production Capacity
7.2.2 France Key Local Oligonucleotides Manufacturers Production
7.2.3 France Key Local Oligonucleotides Manufacturers Production Value
7.2.4 The Proportion of Oligonucleotides Production Sold in France and Sold Other Than France by Manufacturers
7.3 Oligonucleotides Export and Import in France
7.3.1 France Oligonucleotides Export Market
7.3.2 France Oligonucleotides Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for France Oligonucleotides Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON OLIGONUCLEOTIDES SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Oligonucleotides Distributors and Sales Agents in France
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Oligonucleotides in France
Table 2. Top Players in France, Ranking by Revenue (2019)
Table 3. France Oligonucleotides Revenue by Companies, (US$, Mn), 2015-2020
Table 4. France Oligonucleotides Revenue Share by Companies, 2015-2020
Table 5. France Oligonucleotides Sales by Companies, (Million MT), 2015-2020
Table 6. France Oligonucleotides Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Oligonucleotides Price (2015-2020) (USD/MT)
Table 8. France Manufacturers Oligonucleotides Product Type
Table 9. List of France Tier 1 Oligonucleotides Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of France Tier 2 and Tier 3 Oligonucleotides Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Oligonucleotides Revenue in France (US$, Mn), 2015-2020
Table 12. By Type - Oligonucleotides Revenue in France (US$, Mn), 2021-2026
Table 13. By Type - Oligonucleotides Sales in France (Million MT), 2015-2020
Table 14. By Type - Oligonucleotides Sales in France (Million MT), 2021-2026
Table 15. By Application - Oligonucleotides Revenue in France, (US$, Mn), 2015-2020
Table 16. By Application - Oligonucleotides Revenue in France, (US$, Mn), 2021-2026
Table 17. By Application - Oligonucleotides Sales in France, (Million MT), 2015-2020
Table 18. By Application - Oligonucleotides Sales in France, (Million MT), 2021-2026
Table 19. Integrated DNA Technologies Corporate Summary
Table 20. Integrated DNA Technologies Oligonucleotides Product Offerings
Table 21. Integrated DNA Technologies Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 22. Agilent Corporate Summary
Table 23. Agilent Oligonucleotides Product Offerings
Table 24. Agilent Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 25. Sigma-aldrich Corporate Summary
Table 26. Sigma-aldrich Oligonucleotides Product Offerings
Table 27. Sigma-aldrich Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 28. Eurofins Genomics Corporate Summary
Table 29. Eurofins Genomics Oligonucleotides Product Offerings
Table 30. Eurofins Genomics Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 31. L.G.C Biosearch Technologies Corporate Summary
Table 32. L.G.C Biosearch Technologies Oligonucleotides Product Offerings
Table 33. L.G.C Biosearch Technologies Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 34. Eurogentec S.A Corporate Summary
Table 35. Eurogentec S.A Oligonucleotides Product Offerings
Table 36. Eurogentec S.A Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 37. Nitto Denko Avecia Inc Corporate Summary
Table 38. Nitto Denko Avecia Inc Oligonucleotides Product Offerings
Table 39. Nitto Denko Avecia Inc Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 40. GenScript Corporate Summary
Table 41. GenScript Oligonucleotides Product Offerings
Table 42. GenScript Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 43. BBI Life Sciences Corporate Summary
Table 44. BBI Life Sciences Oligonucleotides Product Offerings
Table 45. BBI Life Sciences Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 46. GeneDesign Corporate Summary
Table 47. GeneDesign Oligonucleotides Product Offerings
Table 48. GeneDesign Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 49. TriLink BioTechnologies Corporate Summary
Table 50. TriLink BioTechnologies Oligonucleotides Product Offerings
Table 51. TriLink BioTechnologies Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 52. SGS DNA Corporate Summary
Table 53. SGS DNA Oligonucleotides Product Offerings
Table 54. SGS DNA Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 55. LC Sciences Corporate Summary
Table 56. LC Sciences Oligonucleotides Product Offerings
Table 57. LC Sciences Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 58. Twist Bioscience Corporate Summary
Table 59. Twist Bioscience Oligonucleotides Product Offerings
Table 60. Twist Bioscience Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 61. Creative Biogene Corporate Summary
Table 62. Creative Biogene Oligonucleotides Product Offerings
Table 63. Creative Biogene Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 64. General Biosystems Corporate Summary
Table 65. General Biosystems Oligonucleotides Product Offerings
Table 66. General Biosystems Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 67. Oligonucleotides Production Capacity (Million MT) of Local Manufacturers in France, 2015-2020
Table 68. Oligonucleotides Production (Million MT) of Local Manufacturers in France, 2015-2020
Table 69. France Oligonucleotides Production Market Share of Local Manufacturers, 2015-2020
Table 70. Oligonucleotides Production Value (US$, Mn) of Local Manufacturers in France, 2015-2020
Table 71. France Oligonucleotides Production Value Market Share of Local Manufacturers, 2015-2020
Table 72. The Percentage of Oligonucleotides Production Sold in France and Sold Other Than France by Manufacturers
Table 73. The Percentage of Oligonucleotides Production Sold in France and Sold Other Than France by Manufacturers
Table 74. Dangeguojia Oligonucleotides Sales (Consumption), Production, Export and Import, 2015-2020
Table 75. Raw Materials and Suppliers
Table 76. Oligonucleotides Downstream Clients in France
Table 77. Oligonucleotides Distributors and Sales Agents in France
Table 1. Key Players of Oligonucleotides in France
Table 2. Top Players in France, Ranking by Revenue (2019)
Table 3. France Oligonucleotides Revenue by Companies, (US$, Mn), 2015-2020
Table 4. France Oligonucleotides Revenue Share by Companies, 2015-2020
Table 5. France Oligonucleotides Sales by Companies, (Million MT), 2015-2020
Table 6. France Oligonucleotides Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Oligonucleotides Price (2015-2020) (USD/MT)
Table 8. France Manufacturers Oligonucleotides Product Type
Table 9. List of France Tier 1 Oligonucleotides Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of France Tier 2 and Tier 3 Oligonucleotides Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Oligonucleotides Revenue in France (US$, Mn), 2015-2020
Table 12. By Type - Oligonucleotides Revenue in France (US$, Mn), 2021-2026
Table 13. By Type - Oligonucleotides Sales in France (Million MT), 2015-2020
Table 14. By Type - Oligonucleotides Sales in France (Million MT), 2021-2026
Table 15. By Application - Oligonucleotides Revenue in France, (US$, Mn), 2015-2020
Table 16. By Application - Oligonucleotides Revenue in France, (US$, Mn), 2021-2026
Table 17. By Application - Oligonucleotides Sales in France, (Million MT), 2015-2020
Table 18. By Application - Oligonucleotides Sales in France, (Million MT), 2021-2026
Table 19. Integrated DNA Technologies Corporate Summary
Table 20. Integrated DNA Technologies Oligonucleotides Product Offerings
Table 21. Integrated DNA Technologies Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 22. Agilent Corporate Summary
Table 23. Agilent Oligonucleotides Product Offerings
Table 24. Agilent Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 25. Sigma-aldrich Corporate Summary
Table 26. Sigma-aldrich Oligonucleotides Product Offerings
Table 27. Sigma-aldrich Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 28. Eurofins Genomics Corporate Summary
Table 29. Eurofins Genomics Oligonucleotides Product Offerings
Table 30. Eurofins Genomics Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 31. L.G.C Biosearch Technologies Corporate Summary
Table 32. L.G.C Biosearch Technologies Oligonucleotides Product Offerings
Table 33. L.G.C Biosearch Technologies Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 34. Eurogentec S.A Corporate Summary
Table 35. Eurogentec S.A Oligonucleotides Product Offerings
Table 36. Eurogentec S.A Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 37. Nitto Denko Avecia Inc Corporate Summary
Table 38. Nitto Denko Avecia Inc Oligonucleotides Product Offerings
Table 39. Nitto Denko Avecia Inc Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 40. GenScript Corporate Summary
Table 41. GenScript Oligonucleotides Product Offerings
Table 42. GenScript Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 43. BBI Life Sciences Corporate Summary
Table 44. BBI Life Sciences Oligonucleotides Product Offerings
Table 45. BBI Life Sciences Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 46. GeneDesign Corporate Summary
Table 47. GeneDesign Oligonucleotides Product Offerings
Table 48. GeneDesign Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 49. TriLink BioTechnologies Corporate Summary
Table 50. TriLink BioTechnologies Oligonucleotides Product Offerings
Table 51. TriLink BioTechnologies Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 52. SGS DNA Corporate Summary
Table 53. SGS DNA Oligonucleotides Product Offerings
Table 54. SGS DNA Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 55. LC Sciences Corporate Summary
Table 56. LC Sciences Oligonucleotides Product Offerings
Table 57. LC Sciences Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 58. Twist Bioscience Corporate Summary
Table 59. Twist Bioscience Oligonucleotides Product Offerings
Table 60. Twist Bioscience Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 61. Creative Biogene Corporate Summary
Table 62. Creative Biogene Oligonucleotides Product Offerings
Table 63. Creative Biogene Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 64. General Biosystems Corporate Summary
Table 65. General Biosystems Oligonucleotides Product Offerings
Table 66. General Biosystems Oligonucleotides Sales (Million MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 67. Oligonucleotides Production Capacity (Million MT) of Local Manufacturers in France, 2015-2020
Table 68. Oligonucleotides Production (Million MT) of Local Manufacturers in France, 2015-2020
Table 69. France Oligonucleotides Production Market Share of Local Manufacturers, 2015-2020
Table 70. Oligonucleotides Production Value (US$, Mn) of Local Manufacturers in France, 2015-2020
Table 71. France Oligonucleotides Production Value Market Share of Local Manufacturers, 2015-2020
Table 72. The Percentage of Oligonucleotides Production Sold in France and Sold Other Than France by Manufacturers
Table 73. The Percentage of Oligonucleotides Production Sold in France and Sold Other Than France by Manufacturers
Table 74. Dangeguojia Oligonucleotides Sales (Consumption), Production, Export and Import, 2015-2020
Table 75. Raw Materials and Suppliers
Table 76. Oligonucleotides Downstream Clients in France
Table 77. Oligonucleotides Distributors and Sales Agents in France
LIST OF FIGURES
Figure 1. Oligonucleotides Segment by Type
Figure 2. Oligonucleotides Segment by Application
Figure 3. Dangeguojia Oligonucleotides Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Oligonucleotides Market Size in France, (US$, Mn) & (Million MT): 2020 VS 2026
Figure 6. France Oligonucleotides Revenue, 2015-2026 (US$, Mn)
Figure 7. Oligonucleotides Sales in France: 2015-2026 (Million MT)
Figure 8. The Top 3 and 5 Players Market Share by Oligonucleotides Revenue in 2019
Figure 9. By Type - France Oligonucleotides Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - France Oligonucleotides Market Share, 2015-2020
Figure 11. By Type - France Oligonucleotides Market Share, 2020-2026
Figure 12. By Type - France Oligonucleotides Price (USD/MT), 2015-2026
Figure 13. By Application - Oligonucleotides Revenue in France (US$, Mn), 2020 & 2026
Figure 14. By Application - France Oligonucleotides Market Share, 2015-2020
Figure 15. By Application - France Oligonucleotides Market Share, 2020-2026
Figure 16. By Application -France Oligonucleotides Price (USD/MT), 2015-2026
Figure 17. France Oligonucleotides Production Capacity (Million MT), 2015-2026
Figure 18. France Oligonucleotides Actual Output (Million MT), 2015-2026
Figure 19. France Oligonucleotides Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of France Oligonucleotides Export Destination, 2019
Figure 21. The Source of Imports of France Oligonucleotides, 2019
Figure 22. PEST Analysis for France Oligonucleotides Market in 2020
Figure 23. Oligonucleotides Market Opportunities & Trends in France
Figure 24. Oligonucleotides Market Drivers in France
Figure 25. Oligonucleotides Market Restraints in France
Figure 26. Oligonucleotides Industry Value Chain
Figure 1. Oligonucleotides Segment by Type
Figure 2. Oligonucleotides Segment by Application
Figure 3. Dangeguojia Oligonucleotides Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Oligonucleotides Market Size in France, (US$, Mn) & (Million MT): 2020 VS 2026
Figure 6. France Oligonucleotides Revenue, 2015-2026 (US$, Mn)
Figure 7. Oligonucleotides Sales in France: 2015-2026 (Million MT)
Figure 8. The Top 3 and 5 Players Market Share by Oligonucleotides Revenue in 2019
Figure 9. By Type - France Oligonucleotides Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - France Oligonucleotides Market Share, 2015-2020
Figure 11. By Type - France Oligonucleotides Market Share, 2020-2026
Figure 12. By Type - France Oligonucleotides Price (USD/MT), 2015-2026
Figure 13. By Application - Oligonucleotides Revenue in France (US$, Mn), 2020 & 2026
Figure 14. By Application - France Oligonucleotides Market Share, 2015-2020
Figure 15. By Application - France Oligonucleotides Market Share, 2020-2026
Figure 16. By Application -France Oligonucleotides Price (USD/MT), 2015-2026
Figure 17. France Oligonucleotides Production Capacity (Million MT), 2015-2026
Figure 18. France Oligonucleotides Actual Output (Million MT), 2015-2026
Figure 19. France Oligonucleotides Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of France Oligonucleotides Export Destination, 2019
Figure 21. The Source of Imports of France Oligonucleotides, 2019
Figure 22. PEST Analysis for France Oligonucleotides Market in 2020
Figure 23. Oligonucleotides Market Opportunities & Trends in France
Figure 24. Oligonucleotides Market Drivers in France
Figure 25. Oligonucleotides Market Restraints in France
Figure 26. Oligonucleotides Industry Value Chain
